Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Magenta Therapeutics Inc (MGTA)

Magenta Therapeutics Inc (MGTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGTA, FRG, EMAN

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

MGTA : 11.1936 (-7.74%)
FRG : 29.88 (+0.10%)
EMAN : 2.07 (+2.99%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGTA, CHRA, STSA

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

MGTA : 11.1936 (-7.74%)
STSA : 1.1000 (-0.90%)
Moore Kuehn Encourages RUTH, MGTA, MDWT, and CBOF Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

RUTH : 21.49 (+0.05%)
MGTA : 11.1936 (-7.74%)
MDWT : 26.99 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RUTH, MGTA, OPCH, AMED

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

RUTH : 21.49 (+0.05%)
MGTA : 11.1936 (-7.74%)
OPCH : 26.75 (-0.78%)
AMED : 97.25 (-0.05%)
Shareholder Alert: Ademi LLP investigates whether Magenta Therapeutics, Inc. has obtained a Fair Price in its transaction with Dianthus

/PRNewswire/ -- Ademi LLP is investigating Magenta (Nasdaq: MGTA) for possible breaches of fiduciary duty and other violations of law in its transaction with...

MGTA : 11.1936 (-7.74%)
MAGENTA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Magenta Therapeutics, Inc. - MGTA

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Magenta Therapeutics, Inc. (NasdaqGM: MGTA)...

MGTA : 11.1936 (-7.74%)
MGTA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Magenta Therapeutics, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Magenta Therapeutics, Inc. (NASDAQ: MGTA) and Dianthus Therapeutics, Inc. is fair to Magenta shareholders. Upon completion...

MGTA : 11.1936 (-7.74%)
Pre-Market Brief: Stocks Mostly Higher Ahead of Key U.S. Inflation Data

December S&P 500 futures (ESZ22) are trending up +0.25% this morning after three major US benchmark indices finished the regular session higher as market participants took an optimistic stance ahead of...

ESZ22 : 3,871.47s (-0.66%)
MSFT : 467.56 (+1.47%)
LSEG.LN : 9,333.597 (+0.64%)
MGTA : 11.1936 (-7.74%)
ORCL : 144.83 (+0.31%)
MRTX : 58.70 (-0.17%)
NCLH : 17.48 (-0.34%)
ACMR : 23.94 (+0.29%)
Magenta Therapeutics Reports Second Quarter Financial Results and Recent Program Highlights

– MGTA-117 Phase 1/2 clinical trial progress continues and remains consistent with earlier observations of target binding, target cell reductions, rapid...

MGTA : 11.1936 (-7.74%)
Magenta Therapeutics to Participate in Panel Discussion at the 2022 Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel...

MGTA : 11.1936 (-7.74%)

Barchart Exclusives

3 Standout Stocks to Buy for Q3 2024
As we enter the third quarter of 2024, here are three promising stocks investors could consider buying. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar